FindTrial
Sign In

Knowledge Attitudes and Practices Regarding Starting and Optimizing Treatment in Newly Diagnosed Patients with Type 2 Diabetes and increased HbA1c Approximately 9.8 percent

A cross sectional Survey Assessing Physicians Knowledge Attitudes and Practices in the Management of Newly Diagnosed Type 2 Diabetes Mellitus Patients with Elevated HbA1c approximately 9.8 percent - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/113020
Enrollment
300
Registered
2026-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr. Reddys Laboratories Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthcare professionals practicing in India MBBS (with Diploma in Diabetology) or MD (Medicine) Minimum 5 years (post-MBBS) experience in managing diabetes

Exclusion criteria

Exclusion criteria: Not willing to participate or provide informed consent

Design outcomes

Primary

MeasureTime frame
Assessment of healthcare professionals knowledge attitudes and real-world clinical practices regarding guideline-recommended management and early treatment intensification in newly diagnosed T2DM with high HbA1c including use of combination therapies safety and adherence considerations treatment initiation and escalation strategies follow-up practices and perceived barriers contributing to clinical inertia and suboptimal glycemic managementTimepoint: Day 1—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Simran Chhatwal

Dr. Reddys Laboratories Limited

simranchhatwal@drreddys.com9582711359

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026